These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7041521)

  • 1. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Acta Med Scand; 1982; 211(1-2):35-43. PubMed ID: 7041521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of verapamil on insulin response to alcohol hypoglycemia in patients with primary hyperparathyroidism.
    Röjdmark S
    Diabetes; 1979 Jan; 28(1):21-5. PubMed ID: 759247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus.
    Andersson DE; Röjdmark S
    Acta Med Scand; 1981; 210(1-2):27-33. PubMed ID: 7027745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-antagonistic effects on glucose response to glucagon in patients with non insulin-dependent diabetes mellitus and in normoglycemic subjects.
    Röjdmark S; Andersson DE; Hed R; Sundblad L
    Horm Metab Res; 1981 Dec; 13(12):664-7. PubMed ID: 7033091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of verapamil on glucose response to intravenous injection of glucagon and insulin in healthy subjects.
    Röjdmark S; Andersson DE; Hed R; Sundblad L
    Horm Metab Res; 1980 Jul; 12(7):285-90. PubMed ID: 6995247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of verapamil on human glucose tolerance.
    Röjdmark S; Andersson DE
    Am J Cardiol; 1986 Feb; 57(7):39D-43D. PubMed ID: 3082174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does verapamil influence glucose-induced insulin release in man?
    Röjdmark S; Andersson DE; Hed R; Nordlund A; Sundblad L; Wiechel KL
    Acta Med Scand; 1981; 210(6):501-5. PubMed ID: 7036659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in heart rate by verapamil during carotid sinus stimulation in patients with hyperparathyroidism, pre- and postoperatively.
    Behrmann C; Runge M; Ringe JD
    Basic Res Cardiol; 1992; 87(5):461-4. PubMed ID: 1463430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hypercalcaemia or calcium antagonism affect human melatonin secretion or renal excretion?
    Wikner J; Wetterberg L; Röjdmark S
    Eur J Clin Invest; 1997 May; 27(5):374-9. PubMed ID: 9179543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of verapamil on glucose tolerance.
    Röjdmark S; Andersson DE
    Acta Med Scand Suppl; 1984; 681():37-42. PubMed ID: 6375285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and blood glucose in normal rabbits.
    Patel RB; Shah GF; Raval JD; Gandhi TP; Gilbert RN
    Arzneimittelforschung; 1987 Apr; 37(4):410-2. PubMed ID: 3300662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.
    Dal Ponte DB; Fogt DL; Jacob S; Henriksen EJ
    Metabolism; 1998 Aug; 47(8):982-7. PubMed ID: 9711996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus and carbohydrate metabolism in primary hyperparathyroidism].
    Kautzky-Willer A; Niederle B; Schernthaner G; Prager R
    Wien Klin Wochenschr; 1993; 105(6):158-62. PubMed ID: 8475626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance.
    De Marinis L; Mancini A; Zuppi P; Sammartano L; Valle D; Fiumara C; Sandric S; Folli G
    Diabetes Res; 1992 Jan; 19(1):9-16. PubMed ID: 1468187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose lowering effect of verapamil in fasted man.
    Andersson DE; Röjdmark S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():160-3. PubMed ID: 6398256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.
    Khodneva Y; Shalev A; Frank SJ; Carson AP; Safford MM
    Diabetes Res Clin Pract; 2016 May; 115():115-21. PubMed ID: 26818894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs.
    Gristwood RW; Furman BL; Llenas J; Jauregui J; Berga P
    J Pharm Pharmacol; 1992 Oct; 44(10):851-5. PubMed ID: 1360513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral insulin resistance in primary hyperparathyroidism.
    Prager R; Kovarik J; Schernthaner G; Woloszczuk W; Willvonseder R
    Metabolism; 1983 Aug; 32(8):800-5. PubMed ID: 6346005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.